146 related articles for article (PubMed ID: 35335017)
1. Humoral Immune Response of SARS-CoV-2 Infection and Anti-SARS-CoV-2 Vaccination in Renal Transplant Recipients.
Prasad N; Yadav B; Singh M; Gautam S; Bhadauria D; Patel M; Kushwaha R; Yadav D; Singh A; Yachha M; Behera M; Kaul A
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335017
[TBL] [Abstract][Full Text] [Related]
2. Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center.
Prasad N; Bansal SB; Yadav B; Manhas N; Yadav D; Gautam S; Kushwaha R; Singh A; Bhadauria D; Yachha M; Behera MR; Kaul A
Front Immunol; 2022; 13():911738. PubMed ID: 35844596
[TBL] [Abstract][Full Text] [Related]
3. Higher pro-inflammatory cytokines IL-6 and IFN-γ are associated with anti-SARS-CoV-2 spike protein-specific seroconversion in renal allograft recipients.
Yadav B; Prasad N; Kushwaha RS; Patel MR; Bhadauria D; Kaul A
Transpl Infect Dis; 2023 Oct; 25(5):e14133. PubMed ID: 37605477
[TBL] [Abstract][Full Text] [Related]
4. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines.
Choudhary HR; Parai D; Chandra Dash G; Kshatri JS; Mishra N; Choudhary PK; Pattnaik D; Panigrahi K; Behera S; Ranjan Sahoo N; Podder S; Mishra A; Raghav SK; Mishra SK; Pradhan SK; Sahoo SK; Pattnaik M; Rout UK; Nanda RR; Mondal N; Kanungo S; Palo SK; Bhattacharya D; Pati S
Front Med (Lausanne); 2021; 8():778129. PubMed ID: 35004746
[No Abstract] [Full Text] [Related]
5. Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study.
Singh AK; Phatak SR; Singh R; Bhattacharjee K; Singh NK; Gupta A; Sharma A
Diabetes Metab Syndr; 2022 Feb; 16(2):102424. PubMed ID: 35150961
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital.
Arankalle V; Kulkarni-Munje A; Kulkarni R; Palkar S; Patil R; Oswal J; Lalwani S; Mishra AC
Front Immunol; 2022; 13():928501. PubMed ID: 36211366
[TBL] [Abstract][Full Text] [Related]
7. Clinical Effectiveness of SARS-CoV-2 Vaccination in Renal Transplant Recipients. Antibody Levels Impact in Pneumonia and Death.
Rodríguez-Cubillo B; Moreno de la Higuera MA; Pérez-Flores I; Calvo Romero N; Aiffil AS; Arribi Vilela A; Peix B; Huertas S; Juez A; Sanchez-Fructuoso AI
Transplantation; 2022 Nov; 106(11):e476-e487. PubMed ID: 35859270
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar.
Bansal D; Atia H; Al Badr M; Nour M; Abdulmajeed J; Hasan A; Al-Hajri N; Ahmed L; Ibrahim R; Zamel R; Mohamed A; Pattalaparambil H; Daraan F; Chaudhry A; Oraby S; El-Saleh S; El-Shafie SS; Al-Farsi AF; Paul J; Ismail A; Al-Romaihi HE; Al-Thani MH; Doi SAR; Zughaier SM; Cyprian F; Farag E; Farooqui HH
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992080
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELD
Dash GC; Subhadra S; Turuk J; Parai D; Rath S; Sabat J; Rout UK; Kanungo S; Choudhary HR; Nanda RR; Pattnaik M; Pati S; Bhattacharya D
J Med Virol; 2022 Mar; 94(3):1201-1205. PubMed ID: 34622961
[TBL] [Abstract][Full Text] [Related]
10. Estimation of SARS-CoV-2 IgG Antibodies in Healthcare Worker-Administered Covishield and Covaxin Vaccines at a Tertiary Care Hospital in Jharkhand, India.
Singh B; Seema K; Mahuli AV; Kumar A; Boipai M; Sharma AK; Kumar M; Kumar S; Chandra S; Shahi AK
Cureus; 2023 Oct; 15(10):e47566. PubMed ID: 38021860
[TBL] [Abstract][Full Text] [Related]
11. Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield
Singh AK; Phatak SR; Singh R; Bhattacharjee K; Singh NK; Gupta A; Sharma A
Vaccine; 2021 Oct; 39(44):6492-6509. PubMed ID: 34600747
[TBL] [Abstract][Full Text] [Related]
12. Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.
Jasuja S; Jha V; Sagar G; Bahl A; Verma S; Jasuja N; Kaur J
Clin Kidney J; 2022 Jul; 15(7):1312-1321. PubMed ID: 35747093
[TBL] [Abstract][Full Text] [Related]
13. Dynamicity and persistence of severe acute respiratory syndrome coronavirus-2 antibody response after double dose and the third dose with BBV-152 and AZD1222 vaccines: A prospective, longitudinal cohort study.
Parai D; Choudhary HR; Dash GC; Behera S; Mishra N; Pattnaik D; Raghav SK; Mishra SK; Sahoo SK; Swain A; Mohapatra I; Pattnaik M; Moharana A; Jena SR; Praharaj I; Subhadra S; Kanungo S; Bhattacharya D; Pati S
Front Microbiol; 2022; 13():942659. PubMed ID: 36016787
[TBL] [Abstract][Full Text] [Related]
14. Association of Human Leucocyte Antigen Polymorphism with Coronavirus Disease 19 in Renal Transplant Recipients.
Prasad N; Yadav B; Prakash S; Yadav D; Singh A; Gautam S; Bhadauria D; Kaul A; Patel MR; Behera MR; Kushwaha RS; Yachha M
Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366349
[TBL] [Abstract][Full Text] [Related]
15. Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression.
Thomas RE; Sukumaran A; Krishnan R A; Thomas T; Edwin BT; Haritha PR; Varghese BM; Paul JK; Kumar C S S; Vasudevan DM
Indian J Clin Biochem; 2023 Jan; 38(1):51-58. PubMed ID: 35465605
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring of anti-SARS-CoV-2 IgG antibody immune responses in two cohorts of Hungarian healthcare workers following infection or immunization].
Gervain J; Szabóné Bartha K; Bakiné Hodovánszky E; Kadlecsik L; Herczeg R; Gyenesei A; Simon J
Orv Hetil; 2022 Mar; 163(12):455-462. PubMed ID: 35306478
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response after different SARS-CoV-2 vaccination regimens.
Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review.
Das S; Kar SS; Samanta S; Banerjee J; Giri B; Dash SK
Immunol Res; 2022 Jun; 70(3):289-315. PubMed ID: 35192185
[TBL] [Abstract][Full Text] [Related]
19. Covid-19 Vaccines Available in India.
Mukim M; Sharma P; Patweker M; Patweker F; Kukkar R; Patel R
Comb Chem High Throughput Screen; 2022; 25(14):2391-2397. PubMed ID: 35293291
[TBL] [Abstract][Full Text] [Related]
20. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
